Lord, Abbett & Co
GH icon

Lord, Abbett & Co’s Guardant Health GH Stock Holding History

Lord, Abbett & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272M Sell
1,813,491
-85,622
-5% -$9.31M 0.78% 20
2026
Q1 		$175M Sell
1,899,113
-89,870
-5% -$9.02M 0.57% 43
2025
Q4 		$203M Buy
1,988,983
+465,348
+31% +$41.6M 0.62% 40
2025
Q3 		$95.2M Buy
1,523,635
+635,919
+72% +$34.6M 0.28% 96
2025
Q2 		$46.2M Sell
887,716
-66,777
-7% -$2.98M 0.15% 166
2025
Q1 		$40.7M Buy
+954,493
New +$41.2M 0.14% 178
2024
Q4 		– Sell
-681,074
Closed -$15.6M – 542
2024
Q3 		$15.6M Buy
+681,074
New +$19.3M 0.05% 356
2023
Q4 		– Sell
-644,964
Closed -$19.1M – 545
2023
Q3 		$19.1M Buy
644,964
+199,756
+45% +$7.02M 0.07% 328
2023
Q2 		$15.9M Buy
+445,208
New +$12.8M 0.05% 380
2021
Q2 		– Sell
-80,196
Closed -$12.2M – 664
2021
Q1 		$12.2M Sell
80,196
-254,099
-76% -$38.4M 0.03% 494
2020
Q4 		$43.1M Buy
334,295
+33,868
+11% +$3.9M 0.11% 281
2020
Q3 		$33.6M Buy
300,427
+11,811
+4% +$1.08M 0.11% 285
2020
Q2 		$23.4M Sell
288,616
-57,903
-17% -$4.67M 0.08% 346
2020
Q1 		$24.1M Sell
346,519
-3,421
-1% -$263K 0.11% 291
2019
Q4 		$27.3M Buy
349,940
+109,651
+46% +$7.9M 0.09% 336
2019
Q3 		$15.3M Sell
240,289
-747,079
-76% -$65.8M 0.05% 456
2019
Q2 		$85.2M Buy
987,368
+603,938
+158% +$46.1M 0.28% 100
2019
Q1 		$29.4M Sell
383,430
-149,276
-28% -$8.28M 0.1% 329
2018
Q4 		$20M Buy
+532,706
New +$19.6M 0.07% 393

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Lord, Abbett & Co's GH Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Guardant Health (GH) stake by 4.5% in Q2 2026, selling an estimated $9.31M and leaving 1,813,491 shares worth $272M. The position accounts for 0.78% of the portfolio, ranked #20.

Lord, Abbett & Co first reported a position in GH in Q4 2018 and has held it in 19 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Lord, Abbett & Co held 1,813,491 shares of Guardant Health worth $272M as of Q2 2026.
  • Lord, Abbett & Co sold 85,622 Guardant Health shares in Q2 2026, an estimated $9.31M.
  • Guardant Health made up 0.78% of Lord, Abbett & Co's portfolio in Q2 2026, its #20 holding.
  • Lord, Abbett & Co first reported a position in Guardant Health in Q4 2018 and has held it in 19 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.